Zynerba Pharmaceuticals Inc. (ZYNE) Gained 5.8% or 0.63 To Price $11.5 On Wednesday


Zynerba Pharmaceuticals Inc. (ZYNE) gained 5.8% or 0.63 to $11.5. It is nearly 241307 shares traded, which is 106.26% compare to the average total volume 227098. The market cap of ZYNE is $155.96 million. The year to date change is -10.56%. The 52 week price range is from $5.42 to $20.73. Price of ZYNE have changed -3.89% during last week. It have changed 8.92% over last month, 15.76% over last 3 months, -7.72% over last 6 months and -39.48% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ZYNE is 10.33. It is -10.17% below current price. The 200-day Moving Averages for ZYNE is 10.36. It is -9.91% below current price. The 52-week High is 20.73. It is 80.26% from the current price. The 52-week Low is 5.42. It is -52.87% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of ZYNE is 11.33 on 2018-05-31. Short % to float is 22.45%. There are some statistics of ZYNE. It is has market cap $155.96 million. The share outstanding is 13.56 million. The average volume is 227098. The percent of top 15 Institution holding is 19.20%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ZYNE is -52.82%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ZYNE is -46.93%.


Tags:

Share this post